Search clinical trials for: Placebo drug

Total 265799 results

Artu Biologicals

Completed

Long-term Efficacy and Safety Study With Oralgen Grass Pollen

Allergic Rhinoconjunctivitis

Bulgaria, Lithuania, Czech Republic, Germany, Hungary, Netherlands, Slovakia
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

HIV Infections

United States
Tarsa Therapeutics, Inc.

Completed

A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women (ORACAL)

Osteoporosis, Postmenopausal

United States, United Kingdom, Bulgaria, Hungary, Poland, South Africa
Yooyoung Pharmaceutical Co., Ltd.

Withdrawn

Clinical Trial of YY1201 for Treatment of Osteoarthritis of the Knee

Osteoarthritis, Knee

Korea, Republic of
Chong Kun Dang Pharmaceutical

Unknown

Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet

Hypertension | Dyslipidemias

Korea, Republic of
Guangzhou JOYO Pharma Co., Ltd

Recruiting

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

China
Massachusetts General Hospital
National Institutes of Health (NIH); National Center for Complementary and... and other collaborators

Completed

Study of Maca Root for the Treatment of Antidepressant-Induced Sexual Dysfunction in Females

Antidepressant Induced Sexual Dysfunction

United States
Padagis LLC

Completed

To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis

Actinic Keratosis
Mayo Clinic

Completed

Metformin for the Prevention of Episodic Migraine (MPEM) (MPEM)

Migraine

United States
MedImmune LLC

Terminated

A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple Doses

Healthy Volunteers

United Kingdom
PellePharm, Inc.

Completed

Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients

Basal Cell Nevus Syndrome

United Kingdom
PellePharm, Inc.

Completed

Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas (BCC)

Basal Cell Carcinomas

United States
Lescuyer Laboratory
Université Blaise Pascal, Clermont-Ferrand; Service de Médecine du Sport et...

Completed

Nutrition Effects on Fatigue During Tennis Playing

Fatigue

France
IRCCS Azienda Ospedaliero-Universitaria di Bologna
University of Bologna; University of Leeds; Centre de Recherche en Nutrition... and other collaborators

Terminated

Pivotal Assessment of the Effects of Bioactive on Health and Wellbeing. From Human Genome to Food Industry (PATHWAY-27)

Metabolic Syndrome

United Kingdom, France, Germany, Italy
Amgen

Completed

Single Ascending Dose Study of AMG 570 in Healthy Subjects

Systemic Lupus Erythematosus

United States
Shanghai Vinnerna Biosciences Co., Ltd.
Sponsor GmbH

Terminated

Efficacy and Safety of JT001 (VV116) Compared With Favipiravir

Moderate to Severe COVID-19

China, Uzbekistan
Takeda

Completed

Single-Dose Study of MT203

Healthy Volunteers

Japan
EMS

Not yet recruiting

Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea (LIBERTÀ)

Primary Dysmenorrhea
Nature Cell Co. Ltd.

Not yet recruiting

Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease

Alzheimer Disease
Longboard Pharmaceuticals

Completed

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies (PACIFIC)

Dravet Syndrome | Lennox Gastaut Syndrome | Developmental and Epileptic Encephalopathy

United States, Australia
Shanghai Junshi Bioscience Co., Ltd.

Completed

A Study of JS026 and JS026 Together With JS016 for Treatment of COVID-19

COVID-19

China
Jiangsu HengRui Medicine Co., Ltd.

Enrolling by invitation

To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis

Psoriatic Arthritis

China
Ali Amini Harandi

Unknown

MLC901 for Moderate to Severe Traumatic Brain Injury (Specified Drug Code) (MLC901)

Traumatic Brain Injury

Iran, Islamic Republic of
MyMD Pharmaceuticals, Inc.

Completed

Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty

Frailty | Sarcopenia | Aging

United States
Samjin Pharmaceutical Co., Ltd.

Completed

A Phase 1 Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers

Healthy

Korea, Republic of
Smilebiotek Zhuhai Limited

Active, not recruiting

QA102 Phase II Study in Subjects With Dry AMD (AMEND)

Dry Age-related Macular Degeneration

United States
Chiesi Farmaceutici S.p.A.

Completed

A Study to Compare the Effects of Two Propellants in Adults With Mild Asthma

Asthma

United Kingdom
YSOPIA Bioscience

Completed

Xla1 Christensenella Minuta, Phase I, Randomized, Partially Placebo-controlled Double-blind Protocol, Evaluating Safety, Tolerability and Impact on the Gut Microbiota in Healthy Volunteers, Overweight and Obese Adults (CAUSALITY)

Obesity | Metabolic Disease

United States
Navy General Hospital, Beijing
First People's Hospital of Foshan; General Hospital of Armed Police, Beijing; PLA General Hospital, Beijing

Unknown

Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (WJ-ICMP Tria)

Ischemic Cardiomyopathy
The University of The West Indies

Unknown

Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer

Stage IV Breast Cancer | Stage IV Prostate Cancer | Stage IV Colon Cancer | Stage IV Cancer of the Cervix

Jamaica
Shandong Suncadia Medicine Co., Ltd.

Not yet recruiting

Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .

Overweight and Obesity
Nader Sanai
Eli Lilly and Company; Barrow Neurological Institute; Ivy Brain Tumor Center

Not yet recruiting

Abemaciclib in Newly Diagnosed Meningioma Patients

Meningioma

United States
University of Utah
The Depressive and Bipolar Disorder Alternative Treatment Foundation

Completed

Uridine Adolescent Bipolar Depression Randomized Controlled Trial

Bipolar Disorder | Bipolar Depression | Manic Depression

United States
GlaxoSmithKline

Completed

Oral GW766944 (Oral CCR3 Antagonist)

Asthma

Canada
Ventrus Biosciences, Inc

Terminated

Efficacy and Safety Study to Treat Subjects With Symptomatic Internal Hemorrhoids (VEN309)

Internal Hemorrhoids

United States
AstraZeneca

Recruiting

A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK (ZEAL UNLOCK)

Liver Cirrhosis

Italy, Japan, Germany, Belgium, Poland, Australia, United States, United Kingdom, Czechia, Slovakia
Axolotl Biologix

Terminated

Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects With Ankle Osteoarthritis (Phoenix)

Ankle Osteoarthritis

United States
University of Aarhus

Completed

Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life (HypoPTH)

Hypoparathyroidism

Denmark
Genor Biopharma Co., Ltd.

Unknown

Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects

Rheumatoid Arthritis

China
Neothetics, Inc

Completed

Dose Ranging Study (RESET)

Periumbilical Subcutaneous Adipose Tissue Reduction

United States
Allist Pharmaceuticals, Inc.

Not yet recruiting

To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy (FORWARD)

Non-small Cell Lung Carcinoma
Montefiore Medical Center

Completed

Drug Challenges Without Prior Skin Testing

Drug Hypersensitivity | Penicillin Allergy | Antibiotic Allergy

United States
Novartis

Completed

Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

Partial Onset Seizures

United States, Italy, Germany, Taiwan, Hungary, Switzerland, Bulgaria, Korea, Republic of, Slovakia, Poland
University of Minnesota

Recruiting

Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
Northumbria University
Volac International Ltd

Recruiting

Investigating the Effects of Dietary Phospholipids on Measures of Human Brain Health and Psychological Wellbeing

Cognitive Change | Mood | Well-Being, Psychological

United Kingdom
Inimmune Corporation
Avance Clinical Pty Ltd.

Recruiting

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.

Allergic Rhinitis | Allergic Rhinitis Due to Weed Pollen

Australia
AB Science

Recruiting

Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis (MAXIMS)

Progressive Multiple Sclerosis

Spain, Sweden, France, Greece, Italy, Poland, Russian Federation, Ukraine
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

Chronic Obstructive Pulmonary Disease (COPD

United States, Australia, New Zealand
Biohit Oyj
The Finnish Funding Agency for Technology and Innovation (TEKES)

Completed

The Efficacy of L-cysteine in Prevention of Cluster Headache

Cluster Headache

Finland
Yale University

Completed

Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes

Hyperglycaemia (Diabetic)

United States

Search clinical trials for: Placebo drug

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations